Sorafenib

8 registered clinical trials studyying Sorafenib — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib NCT07463651	The First Affiliated Hospital of Soochow University	Phase 3
Recruiting	A Clinical Study of Sorafenib Combined With Gefitinib for the Treatment of pNET NCT06592989	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	—
Terminated	Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT NCT04709380	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 3
Completed	TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC NCT04518852	Sichuan Cancer Hospital and Research Institute	Phase 2
Terminated	Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC NCT03958669	University Hospital Tuebingen	—
Completed	TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma NCT04103398	Sun Yat-sen University	Phase 3
Unknown	Combined Treatment of RFA and Sorafenib on Recurrent HCC NCT01470495	Southwest Hospital, China	N/A
Completed	Palliative Treatments for Patients With Advanced Hepatocellular Carcinoma (HCC) NCT01409499	Sun Yat-sen University	Phase 4